Veritable, L.P. Opti Nose, Inc. Transaction History

Veritable, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.55 - $3.1 $46,500 - $93,000	-30,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.58 - $7.44 $4,718 - $9,805	-1,318 Reduced 4.21%	30,000 $223,000
Q1 2020 May 13, 2020	SELL	$3.49 - $9.2 $107,268 - $282,771	-30,736 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$4.75 - $8.38 $3,496 - $6,167	736 Added 2.45%	30,736 $215,000
Q1 2018 May 14, 2018	BUY	$15.91 - $20.82 $477,300 - $624,600	30,000 New	30,000 $601,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.